Chiral Balance

Chiral Balance is a life sciences company focused on the development and distribution of D-chiro-inositol (DCI) supplements, primarily targeting Polycystic Ovary Syndrome (PCOS) and related metabolic conditions. The company specializes in providing high-purity DCI, a secondary messenger in the insulin signaling pathway that is often deficient in women with PCOS. By supplementing DCI, Chiral Balance aims to improve insulin sensitivity, restore hormonal balance, and support ovulatory function. Their flagship product, DCI, is marketed directly to consumers and healthcare providers as a natural intervention for metabolic and reproductive health. Founded in 2006, the company emphasizes evidence-based applications and quality control in the nutraceutical space.